Harris is the author of “No More Tears: The Dark Secrets of Johnson & Johnson.” Erythropoietin — also known as EPO — is mostly remembered as the drug that cyclist Lance Armstrong ...

The Erythropoietin (EPO) drugs market is a vital segment of the pharmaceutical industry that focuses on the development and distribution of medications aimed at stimulating red blood cell production.

A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

The global Erythropoietin (EPO) Drugs Market is set for significant expansion, projected to reach USD 12.5 billion by 2033 from USD 7.6 billion in 2023 Renal Diseases Dominate With 40.5% Market ...

Combining EPO inhibition with an immunotherapy that further ... that in 2007 FDA required a black box warning label on the drug cautioning against its use in people with cancers.

During an appearance on Patrick Bet-David's PBD Podcast in March, Sonnen boldly claimed that he and James use the same drug dealer to acquire Erythropoietin (EPO), a banned substance often ...

On Wednesday, the U.S. Anti-Doping Agency announced that Shabliy accepted a six-month suspension for failing a drug test ...

"Among classic doping products used in endurance sports, erythropoietin (EPO) drug, the biological copy of the main EPO hormone responsible for substantial increases in hemoglobin concentration ...

With Chinese swimmers getting 200 drug tests over 10 days ahead of the ... most notably erythropoietin (EPO). Recent research, however, challenges the belief that EPO provides a significant ...